Published: Proceedings and video report of the High-Level Launch Event for EDCTP2

Download the report (PDF)

The proceedings summarise the contributions and discussions at the meeting which marked the launch of EDCTP2. Keynote speeches were delivered by Professor Rose Leke (Chair of the Board of the Cameroon National Medical Research Institute), Professor Peter Piot (Director of the London School of Hygiene and Tropical Medicine) and Dr Paul Stoffels (Worldwide Chairman of Janssen Pharmaceutical Companies of Johnson & Johnson).

Panellists included African and European ministers and high-level policymakers as well as other experts including representatives from industry, international public and private organisations and a patient organisation. The event welcomed approximately 250 delegates and was jointly organised by the European Commission and EDCTP while the South African Department of Science and Technology hosted the event.

Second EDCTP programme
With funding of €1.4 billion from the European Union, the Participating States and third parties, EDCTP2 will support all stages of clinical trials, from phase I to IV, on HIV/AIDS, tuberculosis, malaria and neglected infectious diseases. It will also continue to promote collaborative multicentre projects that combine clinical trials; capacity development in sub-Saharan countries; and closer collaboration with industry, like-minded organisations, and funding agencies for research and development cooperation.

Governance
EDCTP2 will be governed by the EDCTP Association, the implementation structure established in April 2014. This new legal structure enables countries from Europe as well as from sub-Saharan Africa to become members of the EDCTP governing body. The EDCTP Association reflects EDCTP’s commitment to equal partnership built on joint ownership and leadership. Currently, 13 European countries and 13 African countries have joined the Association in order to participate in EDCTP2